Filing Details

Accession Number:
0001127602-22-022417
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-14 16:17:23
Reporting Period:
2022-09-12
Accepted Time:
2022-09-14 16:17:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA Biological Products, (No Disgnostic Substances) (2836) 813467528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760669 Stephen Hoge C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-12 5,000 $10.90 1,630,800 No 4 M Direct
Common Stock Disposition 2022-09-12 5,000 $141.66 1,625,800 No 4 S Direct
Common Stock Acquisiton 2022-09-13 1,972 $10.90 1,627,772 No 4 M Direct
Common Stock Disposition 2022-09-13 1,972 $136.42 1,625,800 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-09-12 5,000 $0.00 5,000 $10.90
Common Stock Stock Option (Right to Buy) Disposition 2022-09-13 1,972 $0.00 1,972 $10.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,972 2026-02-23 No 4 M Direct
0 2026-02-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,116 Indirect By Valhalla, LLC
Common Stock 151,933 Indirect By Trust
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.
  2. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  3. This option is fully vested and exercisable.